Published in Neurology on February 13, 2007
Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord (2011) 2.02
Psychiatric symptoms associated with focal hand dystonia. Mov Disord (2010) 1.47
SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain (2013) 1.05
The genetics of dystonia: new twists in an old tale. Brain (2013) 0.98
SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. J Neurol (2014) 0.95
Nonmotor manifestations of dystonia: a systematic review. Mov Disord (2011) 0.95
Psychiatric disorders in rapid-onset dystonia-parkinsonism. Neurology (2012) 0.92
Clinical and neurophysiological improvement of SGCE myoclonus-dystonia with GPi deep brain stimulation. Clin Neurol Neurosurg (2009) 0.89
CACNA1B mutation is linked to unique myoclonus-dystonia syndrome. Hum Mol Genet (2014) 0.87
New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism. Parkinsonism Relat Disord (2012) 0.86
Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord (2013) 0.85
Substance abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev (2012) 0.83
Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology (2012) 0.80
Psychiatric disorders, myoclonus dystonia and SGCE: an international study. Ann Clin Transl Neurol (2015) 0.78
Schizophrenia and birthplace of paternal and maternal grandfather in the Jerusalem perinatal cohort prospective study. Schizophr Res (2009) 0.77
Psychiatric disorders in primary focal dystonia and in Parkinson's disease. Neuropsychiatr Dis Treat (2011) 0.75
The relationship between the dopaminergic system and depressive symptoms in cervical dystonia. Eur J Nucl Med Mol Imaging (2017) 0.75
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
NDT80, a meiosis-specific gene required for exit from pachytene in Saccharomyces cerevisiae. Mol Cell Biol (1995) 3.82
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res (1998) 3.77
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature (1988) 3.27
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Classification of dystonia. Adv Neurol (1998) 2.75
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
The DYT1 phenotype and guidelines for diagnostic testing. Neurology (2000) 2.39
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Functional brain networks in DYT1 dystonia. Ann Neurol (1998) 2.14
Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science (1987) 2.06
Nucleotide sequence of the large double-stranded RNA segment of bacteriophage phi 6: genes specifying the viral replicase and transcriptase. J Virol (1988) 1.95
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet (2000) 1.90
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol (1990) 1.89
Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology (1997) 1.88
The UV response involving the Ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell (1994) 1.85
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain (2005) 1.78
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology (2012) 1.77
Identification of a highly polymorphic microsatellite VNTR within the argininosuccinate synthetase locus: exclusion of the dystonia gene on 9q32-34 as the cause of dopa-responsive dystonia in a large kindred. Am J Hum Genet (1991) 1.77
alpha-Synuclein and Parkinson disease susceptibility. Neurology (2007) 1.72
Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry (2009) 1.70
Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol (1999) 1.67
Delayed-onset cerebellar syndrome. Arch Neurol (1996) 1.65
Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology (2008) 1.60
Analysis of blink rate patterns in normal subjects. Mov Disord (1997) 1.57
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology (2010) 1.57
Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology (2011) 1.57
Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol (2003) 1.56
Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol (2001) 1.55
Sensory abnormalities in unaffected relatives in familial adult-onset dystonia. Neurology (2005) 1.53
Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Neuropediatrics (2007) 1.52
Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy. Mov Disord (1998) 1.51
Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron (1989) 1.51
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann Neurol (1994) 1.47
Regional metabolism in primary torsion dystonia: effects of penetrance and genotype. Neurology (2004) 1.46
Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology (1991) 1.46
Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi Jews. Am J Hum Genet (1992) 1.46
Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem (1999) 1.45
The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology (1999) 1.44
D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Results from four large kindreds. Arch Neurol (1994) 1.43
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology (2007) 1.42
Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro. J Bone Miner Res (1997) 1.40
Parkinson's disease in twins: a follow-up study. Neurology (1999) 1.40
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol (2000) 1.40
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology (2005) 1.38
The effect of halothane on the recirculatory pharmacokinetics of physiologic markers. Anesthesiology (1997) 1.38
[Treatment of sialorrhea with botulinum toxin: an overview]. Nervenarzt (2005) 1.38
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry (2000) 1.36
Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat Genet (1993) 1.36
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology (2005) 1.34
Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol (1997) 1.34
Induction of phosphodiesterase by cyclic adenosine 3':5'-monophosphate in differentiating Dictyostelium discoideum amoebae. J Biol Chem (1975) 1.33
Fate of virus DNA in the abortive infection of human lymphoid cell lines by Epstein-Barr virus. J Gen Virol (1972) 1.33
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology (2002) 1.32
Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology (1999) 1.31
Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am J Hum Genet (1990) 1.31
Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry (2001) 1.30
The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet (1994) 1.30